Abstract:Abstract Cutaneous graft-versus-host disease (GVHD) is a well-recognized complication, occurring in 60–80% of patients after allogeneic bone marrow stem cell transplantation (BMSCT) (Garbutcheon-Singh KB, Fernández-Peñas P. Phototherapy for the treatment of cutaneous graft-versus-host disease. Australas J Dermatol 2015; 56: 93–9). The chronic type manifests as either a lichenoid or sclerodermatous form. Phototherapy is an effective treatment option as it works by immunomodulatory effects. We retrospectively reviewed eight cases of chronic cutaneous GVHD. All the patients had undergone allogeneic BMSCT for an underlying haematological disorder at a tertiary care centre in western India. Each patient was administered phototherapy with ultraviolet (UV)A radiation twice a week. All of them received 8-methoxypsoralen at a dose of 0.6 mg kg−1 as a photosensitizer, 2 h prior to UVA therapy. The percentage improvement in body surface area involved was calculated at the end of therapy and results were analysed using SPSS. Also, the doses of steroids and immunosuppressants were tapered while the patient was on phototherapy. A total of eight patients were enrolled in the study; five (63%) were male (63%) and three (38%) were female. The mean age at the time of presentation was 37.75 years. Five patients (63%) had lichenoid GVHD, while the other three cases (38%) had sclerodermatous type GVHD. Six patients had undergone allogeneic BMSCT for leukaemia, while one patient had myelofibrosis and one case was diagnosed with Diamond–Blackfan syndrome. The mean time to develop GVHD after bone marrow transplant was 9.5 months and the mean body surface area involved at the time of diagnosis was 50.6%. There was more than 50% improvement in five cases (63%) after an average of 36.3 sessions of psoralen plus UVA (PUVA), while one case (13%) relapsed after achieving complete remission. One patient (13%) was lost to follow-up as he was not able to visit the hospital frequently for twice-weekly sessions. One patient (13%) died while on PUVA therapy owing to relapse of leukaemia. Generally, all the patients tolerated PUVA well, except two patients who experienced nausea after taking psoralen, one patient with dizziness after PUVA therapy and one patient who complained of pigmentation of skin over the extremities. The percentage reduction in the dose of steroids before and after phototherapy was also found to be statistically significant. We conclude that PUVA therapy is an effective nonaggressive modality for treating chronic cutaneous GVHD, especially the lichenoid form. It offers a major advantage of an immunosuppressive sparing effect as well as a good safety profile.

Acute Skin Lesions Following Psoralen Plus Ultraviolet A Radiation Investigated by Optical Coherence Tomography

Quantitative Analysis on PUVA-induced Skin Photodamages Using Optical Coherence Tomography

Monitoring Skin Photodamage Using Quantitative Optical Coherence Tomography

Quantitative Analysis on PUVA-induced Skin Lesions and the Photoprotective Effect Induced by Vitamin C Using Optical Coherence Tomography

Quantitative optical coherence tomography of skin lesions induced by different ultraviolet B sources.

Assessment of the Effect of Narrowband UVB and Broadband UVB on Mice Skin Using Optical Coherence Tomography

Multiparametric Quantitative Analysis of Photodamage to Skin Using Optical Coherence Tomography

Comparison of the effect of 8-methoxypsoralen (8-MOP) plus UVA (PUVA) on human melanocytes in vitiligo vulgaris and in vitro

UVA radiation augments cytotoxic activity of psoralens in melanoma cells

Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris

Role Of Vegf Receptors In Normal And Psoriatic Human Keratinocytes: Evidence From Irradiation With Different Uv Sources

Kinetics of phototoxicity in trioxysalen bath psoralen plus ultraviolet A photochemotherapy

5-Aminolevulinic Acid-Based Photodynamic Therapy Pretreatment Mitigates Ultraviolet A-Induced Oxidative Photodamage.

Enhanced inflammation and immunosuppression by ultraviolet radiation in xeroderma pigmentosum group A (XPA) model mice

Study on Regulation of Melanogenesis Induced by 8-Methoxypsoralen and Related Signal Transduction Pathways in Murine Melanoma Cells

BI37 Efficacy of psoralen plus ultraviolet A therapy for the treatment of chronic cutaneous graft-versus-host disease: a retrospective study analysis from a tertiary care centre

Psoralen derivatives and longwave ultraviolet irradiation are active in vitro against human melanoma cell line

Carcinogenic effects of prolonged daily low-emission phototherapy in psoriasis

[Phototoxic reaction due to solar radiation exposure in a psoriatic patient treated with PUVA therapy]

Using Multiphoton Microscopy to Image the Skin of Mouse Psoriasis Model

The cardiovascular stress of photochemotherapy (PUVA)